Showing 1 - 2 results of 2 for search 'Concepción Ruiz Nuño', query time: 0.02s Refine Results
  1. 1
    P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA

    P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA by Valentin Garcia Gutierrez, Juan Carlos Hernandez-Boluda, Luis Felipe Casado Montero, M Teresa Gómez Casares, Rosa Ayala Diaz, Blanca Xicoy Cirici, Francisca Ferrer-Marín, Guillermo Ortí, Raquel De Paz Arias, Santiago Ossorio Prendes, Raúl Pérez López, Elvira Mora Castera, Concepcion Ruiz Nuño, Antonio Jimenez, Concepcion Boque Genovard, Magdalena Sierra, Joaquín Martinez-Lopez

    Published 2023-08-01
    Get full text
    Article
  2. 2
    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.

    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia. by Valentín García-Gutiérrez, María T Gómez-Casares, José M Puerta, Juan M Alonso-Domínguez, Santiago Osorio, Juan C Hernández-Boluda, Rosa Collado, María J Ramírez, Fátima Ibáñez, María L Martín, Juan D Rodríguez-Gambarte, Carolina Martínez-Laperche, Montse Gómez, Dolly V Fiallo, Sara Redondo, Alicia Rodríguez, Concepción Ruiz-Nuño, Juan L Steegmann, Antonio Jiménez-Velasco, Spanish Group of Chronic Myeloid Leukemia (GELMC)

    Published 2017-01-01
    Get full text
    Article

Search Tools: